A detailed history of Wesbanco Bank Inc transactions in Novo Nordisk A S stock. As of the latest transaction made, Wesbanco Bank Inc holds 103,116 shares of NVO stock, worth $8.71 Million. This represents 0.31% of its overall portfolio holdings.

Number of Shares
103,116
Previous 83,892 22.92%
Holding current value
$8.71 Million
Previous $9.99 Million 11.2%
% of portfolio
0.31%
Previous 0.35%

Shares

5 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q4 2024

Jan 17, 2025

BUY
$85.0 - $120.04 $1.63 Million - $2.31 Million
19,224 Added 22.92%
103,116 $8.87 Million
Q3 2024

Oct 11, 2024

BUY
$119.07 - $145.42 $2.61 Million - $3.19 Million
21,904 Added 35.34%
83,892 $9.99 Million
Q2 2024

Jul 11, 2024

BUY
$122.71 - $146.91 $2.92 Million - $3.5 Million
23,796 Added 62.31%
61,988 $8.85 Million
Q1 2024

Apr 23, 2024

BUY
$102.11 - $135.92 $3.9 Million - $5.19 Million
38,192 New
38,192 $4.9 Million
Q2 2023

Jul 13, 2023

BUY
$155.98 - $172.65 $516,137 - $571,298
3,309 New
3,309 $535,000

Others Institutions Holding NVO

About NOVO NORDISK A S


  • Ticker NVO
  • Exchange OTC
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 2,257,289,984
  • Market Cap $191B
  • Description
  • Novo Nordisk A/S, a healthcare company, engages in the research, development, manufacture, and marketing of pharmaceutical products worldwide. It operates in two segments, Diabetes and Obesity care, and Biopharm. The Diabetes and Obesity care segment provides products in the areas of insulins, GLP-1 and related delivery systems, oral antidiabeti...
More about NVO
Track This Portfolio

Track Wesbanco Bank Inc Portfolio

Follow Wesbanco Bank Inc and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Wesbanco Bank Inc, based on Form 13F filings with the SEC.

News

Stay updated on Wesbanco Bank Inc with notifications on news.